JP2023165983A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023165983A5 JP2023165983A5 JP2023169604A JP2023169604A JP2023165983A5 JP 2023165983 A5 JP2023165983 A5 JP 2023165983A5 JP 2023169604 A JP2023169604 A JP 2023169604A JP 2023169604 A JP2023169604 A JP 2023169604A JP 2023165983 A5 JP2023165983 A5 JP 2023165983A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- seq
- acid sequence
- antigen
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862678890P | 2018-05-31 | 2018-05-31 | |
| US62/678,890 | 2018-05-31 | ||
| PCT/US2019/034708 WO2019232246A1 (en) | 2018-05-31 | 2019-05-30 | Therapeutic antibodies binding to biantennary lewis b and lewis y antigens |
| JP2020566286A JP7360401B2 (ja) | 2018-05-31 | 2019-05-30 | バイアンテナ型ルイスｂおよびルイスｙ抗原に結合する治療抗体 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566286A Division JP7360401B2 (ja) | 2018-05-31 | 2019-05-30 | バイアンテナ型ルイスｂおよびルイスｙ抗原に結合する治療抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023165983A JP2023165983A (ja) | 2023-11-17 |
| JP2023165983A5 true JP2023165983A5 (https=) | 2023-12-18 |
| JP7696404B2 JP7696404B2 (ja) | 2025-06-20 |
Family
ID=66952044
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566286A Active JP7360401B2 (ja) | 2018-05-31 | 2019-05-30 | バイアンテナ型ルイスｂおよびルイスｙ抗原に結合する治療抗体 |
| JP2023169604A Active JP7696404B2 (ja) | 2018-05-31 | 2023-09-29 | バイアンテナ型ルイスｂおよびルイスｙ抗原に結合する治療抗体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566286A Active JP7360401B2 (ja) | 2018-05-31 | 2019-05-30 | バイアンテナ型ルイスｂおよびルイスｙ抗原に結合する治療抗体 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US11440967B2 (https=) |
| EP (1) | EP3802604A1 (https=) |
| JP (2) | JP7360401B2 (https=) |
| KR (1) | KR102480815B1 (https=) |
| CN (1) | CN112533948B (https=) |
| AU (1) | AU2019278875B2 (https=) |
| BR (1) | BR112020023380A2 (https=) |
| CA (1) | CA3106380A1 (https=) |
| IL (1) | IL279109B2 (https=) |
| MX (1) | MX2020011385A (https=) |
| SG (1) | SG11202010025YA (https=) |
| TW (1) | TWI842712B (https=) |
| WO (1) | WO2019232246A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3802604A1 (en) * | 2018-05-31 | 2021-04-14 | Glyconex Inc. | Therapeutic antibodies binding to biantennary lewis b and lewis y antigens |
| CN120025447A (zh) * | 2023-11-23 | 2025-05-23 | 广东菲鹏制药股份有限公司 | 抗人pvrig抗体及其应用 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4237224A (en) | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
| IL94872A (en) | 1989-06-30 | 1995-03-30 | Oncogen | Monoclonal or chimeric antibodies reactive with human carcinomas, recombinant proteins comprising their antigen binding region, pharmaceutical compositions and kits comprising said antibodies and methods for imaging human carcinoma using same |
| US5151510A (en) | 1990-04-20 | 1992-09-29 | Applied Biosystems, Inc. | Method of synethesizing sulfurized oligonucleotide analogs |
| US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
| ATE207080T1 (de) | 1991-11-25 | 2001-11-15 | Enzon Inc | Multivalente antigen-bindende proteine |
| JPH0693A (ja) * | 1992-04-23 | 1994-01-11 | Otsuka Pharmaceut Co Ltd | モノクローナル抗体 |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US5792456A (en) | 1994-08-04 | 1998-08-11 | Bristol-Myers Squibb Company | Mutant BR96 antibodies reactive with human carcinomas |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US6833268B1 (en) | 1999-06-10 | 2004-12-21 | Abgenix, Inc. | Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions |
| US6323039B1 (en) | 1999-06-22 | 2001-11-27 | Mitokor | Compositions and methods for assaying subcellular conditions and processes using energy transfer |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| GB0111628D0 (en) | 2001-05-11 | 2001-07-04 | Scancell Ltd | Binding member |
| ATE492562T1 (de) | 2003-09-24 | 2011-01-15 | Kyowa Hakko Kirin Co Ltd | Rekombinanter antikörper gegen humanen insulin- like growth factor |
| EP2064244B1 (en) * | 2006-08-03 | 2019-06-05 | MedImmune Limited | ANTIBODIES DIRECTED TO alphaVbeta6 AND USES THEREOF |
| CN101547937A (zh) * | 2006-09-20 | 2009-09-30 | 阿拉纳治疗有限公司 | 抗Lewisy和Lewisb抗原的抗癌抗体 |
| EP2097447A4 (en) * | 2006-11-15 | 2010-12-29 | Medarex Inc | HUMAN MONOCLONAL ANTIBODIES AGAINST BTLA AND METHODS OF USE |
| EP2210903A1 (en) | 2009-01-21 | 2010-07-28 | Monoclonal Antibodies Therapeutics | Anti-CD160 monoclonal antibodies and uses thereof |
| EP2640745B1 (en) | 2010-09-10 | 2018-11-07 | MedImmune Limited | Bivalent and bispecific anti-il6/anti-il23 antibodies |
| US9676854B2 (en) | 2011-08-15 | 2017-06-13 | Medimmune, Llc | Anti-B7-H4 antibodies and their uses |
| CA2894879A1 (en) | 2012-12-19 | 2014-06-26 | Amplimmune, Inc. | B7-h4 specific antibodies, and compositions and methods of use thereof |
| WO2016040724A1 (en) | 2014-09-12 | 2016-03-17 | Genentech, Inc. | Anti-b7-h4 antibodies and immunoconjugates |
| RU2017115315A (ru) | 2014-10-03 | 2018-11-08 | Дана-Фарбер Кэнсер Инститьют, Инк. | Антитела к рецептору глюкокортикоид-индуцированного фактора некроза опухоли (gitr) и способы их применения |
| DK3653221T5 (da) | 2015-02-19 | 2024-08-26 | Compugen Ltd | Anti-pvrig-antistoffer og anvendelsesfremgangsmåder |
| JO3620B1 (ar) | 2015-08-05 | 2020-08-27 | Amgen Res Munich Gmbh | مثبطات نقطة فحص مناعية للاستخدام في علاج سرطانات محمولة عبر الدم |
| EP3802604A1 (en) * | 2018-05-31 | 2021-04-14 | Glyconex Inc. | Therapeutic antibodies binding to biantennary lewis b and lewis y antigens |
-
2019
- 2019-05-30 EP EP19731849.6A patent/EP3802604A1/en active Pending
- 2019-05-30 US US16/427,146 patent/US11440967B2/en active Active
- 2019-05-30 AU AU2019278875A patent/AU2019278875B2/en active Active
- 2019-05-30 MX MX2020011385A patent/MX2020011385A/es unknown
- 2019-05-30 CN CN201980036582.XA patent/CN112533948B/zh active Active
- 2019-05-30 BR BR112020023380-3A patent/BR112020023380A2/pt unknown
- 2019-05-30 SG SG11202010025YA patent/SG11202010025YA/en unknown
- 2019-05-30 IL IL279109A patent/IL279109B2/en unknown
- 2019-05-30 CA CA3106380A patent/CA3106380A1/en active Pending
- 2019-05-30 KR KR1020207035837A patent/KR102480815B1/ko active Active
- 2019-05-30 WO PCT/US2019/034708 patent/WO2019232246A1/en not_active Ceased
- 2019-05-30 JP JP2020566286A patent/JP7360401B2/ja active Active
- 2019-05-31 TW TW108119035A patent/TWI842712B/zh active
-
2022
- 2022-07-26 US US17/815,117 patent/US11643471B2/en active Active
-
2023
- 2023-02-28 US US18/175,905 patent/US20240067746A1/en active Pending
- 2023-09-29 JP JP2023169604A patent/JP7696404B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| King et al. | Improved tumor targeting with chemically cross-linked recombinant antibody fragments | |
| US20200255537A1 (en) | Internalizing human monoclonal antibodies targeting prostate cancer cells in situ | |
| US20220064324A1 (en) | Cross species single domain antibodies targeting mesothelin for treating solid tumors | |
| CN105026429B (zh) | 间皮素结构域-特异性单克隆抗体及其用途 | |
| JP2023165983A5 (https=) | ||
| CA2996205A1 (en) | Monoclonal antibodies specific for fibroblast growth factor receptor 4 (fgfr4) and methods of their use | |
| US12122843B2 (en) | High affinity monoclonal antibodies targeting glypican-1 and methods of use | |
| US20180214568A1 (en) | Antibody-drug conjugates for targeting cd56-positive tumors | |
| JP2019518068A (ja) | グリコシル化免疫チェックポイントタンパク質に特異的に結合する抗体を選択する方法 | |
| US10132799B2 (en) | Screening of conjugated antibodies | |
| WO2016022939A1 (en) | Human monoclonal antibodies specific for 5t4 and methods of their use | |
| CA3066953A1 (en) | Human monoclonal antibodies specific for cd33 and methods of their use | |
| WO2023207475A1 (zh) | 靶向gpc3的单克隆抗体和包含此抗体的抗体药物缀合物 | |
| JP2024545170A5 (https=) | ||
| AU763162B2 (en) | Diagnostic and therapeutic use of antibodies against the urokinase receptor | |
| WO2024238346A1 (en) | Single domain antibodies that specifically bind the s2 subunit of sars-cov-2 spike protein and compositions and uses thereof | |
| US20240218055A1 (en) | Lassa virus-specific nanobodies and methods of their use | |
| CN119505001B (zh) | 靶向cd22的全人源抗体及其应用 | |
| WO2002055089A9 (en) | Immunoassay technique using multispecific molecules | |
| CN118234750A (zh) | 抗cd33抗体和其用途 | |
| RU2020141986A (ru) | Терапевтические антитела, связывающиеся с биантеннарными антигенами льюиса b и льюиса y | |
| EP4722245A1 (en) | Antibody targeting itga2, antibody drug conjugate thereof, and use | |
| HK40120624A (zh) | Nectin-4结合剂 | |
| WO2021141996A1 (en) | Single- and multi-chain polypeptides that bind specifically to cd3 epsilon | |
| WO2025151746A1 (en) | Methods and compositions for the treatment of pou2f3-driven cancer |